BD acquires TVA Medical to advance leadership in solutions for chronic kidney disease

BD (Becton, Dickinson and Company) has completed the acquisition of TVA Medical, Inc., a company that develops minimally invasive vascular access solutions for patients with chronic kidney disease requiring hemodialysis. The addition of TVA Medical enables BD to offer the everlinQ endoAVF system, a new endovascular arteriovenous (AV) fistula creation technology that adds to the company’s ESRD portfolio of dialysis catheters, drug coated balloons, standard angioplasty balloons, and endovascular stent graft products.

This technology will further improve BD’s ability to serve physicians and their patients by providing a minimally invasive option for creating critical AV fistulas (joining arteries to veins to create a circuit) for hemodialysis procedures.